Maybe it is too hot to blog but I wanted to mention some “goings on” in our Pharmaceutical practice. We have an upcoming trial in Philadelphia in our hormone therapy litigation. Wyeth is listed as the defendant, but Pfizer bought them at the end of 2009. At this point, I expect that the trial will go forward. It involves one of our Virginia clients. In addition, the Philadelphia Judge will soon be ruling on combining plaintiffs in one trial. That would move the litigation forward and create less expense for each of our clients.
We are still completing disbursements to our Vioxx clients. Under the original terms of the settlement, the disbursements are in waves, based on the type of injury that was suffered. In addition, Merck paid, subject to approval of the Judge, of each of the costs and fees.
That’s a quick summary of a couple of the drug litigation course of events. Of course, we are always on the look out for other possible drugs that may be causing injury. Sometimes, a prospective client will send me information of an injury that they believe was caused by some prescription. That’s why, I have titled this “On the Lookout” because I believe that people calling to report bad drugs have made our medications safer and the FDA more aware. We all benefit when people call.